Mohammed Kashani-Sabet

12PUBLICATIONS
33CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersLiquid biopsiesNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 25, 2026
Retrospective Study of Trametinib in Patients With Advanced NF1-Mutant Melanoma.

Lin Wang, Mohammed Kashani-Sabet, Prasad Dighe

|May 15, 2025
Phase II Study of Niraparib in Patients With Advanced Melanoma With Homologous Recombination Pathway Gene Mutations.

Kevin B Kim, Pierre-Yves Desprez, David de Semir

|Aug 13, 2024
miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK.

Vladimir Bezrookove, Imran Khan, Anukana Bhattacharjee

|Aug 10, 2024
Preoperative and Intraoperative Identification of Sentinel Lymph Nodes in Melanoma Surgery.

Stanley P Leong, Mehdi Nosrati, Max C Wu

|Jul 13, 2023
Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures.

Stephen H Chang, Ryan J Ice, Michelle Chen

Pageof 2